Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Arcus Biosciences Stock News

RCUSNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$8.30

-0.11-1.31%

At close: -

$8.30

0.000.00%

After Hours: Apr 25, 4:00 PM EDT

Q1 2025 Earnings in 9 days from now on Tue May 6th, after the market close

Arcus Biosciences (RCUS) Forecast

News

Earnings Arcus Biosciences (RCUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Arcus Biosciences Stock News | NYSE:RCUS | Benzinga

Get the latest news on Arcus Biosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Arcus Biosciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, April 23, 2025

Forecasting The Future: 5 Analyst Projections For Arcus Biosciences
Benzinga Insights - 3 days ago
Barclays Maintains Overweight on Arcus Biosci...
Benzinga Newsdesk - 3 days ago

Wednesday, February 26, 2025

HC Wainwright & Co. Upgrades Arcus Bioscience...
Benzinga Newsdesk - Feb 26, 2025, 7:40AM

Tuesday, February 25, 2025

Arcus Biosciences Q4 EPS $(1.03) Beats $(1.32...
Benzinga Newsdesk - Feb 25, 2025, 4:36PM
Earnings Scheduled For February 25, 2025
Benzinga Insights - Feb 25, 2025, 3:32AM

Wednesday, February 19, 2025

B of A Securities Maintains Neutral on Arcus ...
Benzinga Newsdesk - Feb 19, 2025, 6:58AM

Tuesday, February 18, 2025

Arcus Biosciences Shares Are Down Today: What's Going On?
Vaishali Prayag - Feb 18, 2025, 4:14PM
HC Wainwright & Co. Maintains Neutral on Arcu...
Benzinga Newsdesk - Feb 18, 2025, 1:12PM
Morgan Stanley Maintains Overweight on Arcus ...
Benzinga Newsdesk - Feb 18, 2025, 12:34PM
Arcus Biosciences shares are trading lower af...
Benzinga Newsdesk - Feb 18, 2025, 11:47AM
Arcus Biosciences Announces Gilead's Time-Lim...
Benzinga Newsdesk - Feb 18, 2025, 6:59AM
Arcus Biosciences Prices Offering Of 13.636M ...
Benzinga Newsdesk - Feb 18, 2025, 6:55AM

Monday, February 17, 2025

Arcus Biosciences Says New Data Demonstrated ...
Benzinga Newsdesk - Feb 17, 2025, 7:26AM

Monday, February 10, 2025

Arcus Biosciences Plans To Present New Data f...
Benzinga Newsdesk - Feb 10, 2025, 5:21PM

Friday, January 31, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jan 31, 2025, 7:05AM

Friday, January 24, 2025

Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor - Jan 24, 2025, 8:06AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jan 24, 2025, 7:06AM

Wednesday, November 06, 2024

Arcus Biosciences Q3 2024 GAAP EPS $(1.00) Be...
Benzinga Newsdesk - Nov 6, 2024, 4:45PM
Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts
Benzinga Insights - Nov 6, 2024, 7:00AM
HC Wainwright & Co. Reiterates Neutral on Arc...
Benzinga Newsdesk - Nov 6, 2024, 4:57AM

Tuesday, November 05, 2024

Arcus Biosciences Announces That Domvanalimab...
Benzinga Newsdesk - Nov 5, 2024, 9:14AM

Friday, October 25, 2024

Barclays Maintains Overweight on Arcus Biosci...
Benzinga Newsdesk - Oct 25, 2024, 1:32PM

Thursday, October 24, 2024

HC Wainwright & Co. Reiterates Neutral on Arc...
Benzinga Newsdesk - Oct 24, 2024, 3:21PM
Arcus Biosciences shares are trading higher a...
Benzinga Newsdesk - Oct 24, 2024, 7:58AM
Arcus Biosciences Presented The First Clinica...
Benzinga Newsdesk - Oct 24, 2024, 7:47AM

Monday, October 21, 2024

Arcus Biosciences shares are trading lower. H...
Benzinga Newsdesk - Oct 21, 2024, 3:43PM
Unveiling 5 Analyst Insights On Arcus Biosciences
Benzinga Insights - Oct 21, 2024, 10:00AM
Where Arcus Biosciences Stands With Analysts
Benzinga Insights - Oct 21, 2024, 8:00AM
HC Wainwright & Co. Initiates Coverage On Arc...
Benzinga Newsdesk - Oct 21, 2024, 6:47AM

Tuesday, October 08, 2024

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor - Oct 8, 2024, 9:03AM
Wells Fargo Initiates Coverage On Arcus Biosc...
Benzinga Newsdesk - Oct 8, 2024, 8:44AM

Monday, October 07, 2024

Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk - Oct 7, 2024, 10:15AM

Thursday, October 03, 2024

Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk - Oct 3, 2024, 11:02AM
Demystifying Arcus Biosciences: Insights From 4 Analyst Reviews
Benzinga Insights - Oct 3, 2024, 10:00AM
Wedbush Reiterates Outperform on Arcus Biosci...
Benzinga Newsdesk - Oct 3, 2024, 9:44AM

Wednesday, October 02, 2024

Arcus Biosciences Announces Clinical Trial Co...
Benzinga Newsdesk - Oct 2, 2024, 4:07PM

Friday, August 09, 2024

Arcus Biosciences shares are trading higher a...
Benzinga Newsdesk - Aug 9, 2024, 12:54PM
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
Benzinga Insights - Aug 9, 2024, 12:00PM
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk - Aug 9, 2024, 11:11AM
Wedbush Reiterates Outperform on Arcus Biosci...
Benzinga Newsdesk - Aug 9, 2024, 9:32AM

Thursday, August 08, 2024

Arcus Biosciences Q2 2024 GAAP EPS $(1.02) Be...
Benzinga Newsdesk - Aug 8, 2024, 4:10PM

Monday, July 08, 2024

Arcus Biosciences Says Taiho Exercised Its Op...
Benzinga Newsdesk - Jul 8, 2024, 6:07PM
Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences
Benzinga Insights - Jul 8, 2024, 5:00PM
Barclays Maintains Overweight on Arcus Biosci...
Benzinga Newsdesk - Jul 8, 2024, 3:59PM

Friday, July 05, 2024

Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk - Jul 5, 2024, 12:15PM

Monday, June 24, 2024

Truist Securities Maintains Buy on Arcus Bios...
Benzinga Newsdesk - Jun 24, 2024, 9:43AM

Monday, June 10, 2024

Arcus Biosciences In Collaboration With Gilea...
Benzinga Newsdesk - Jun 10, 2024, 8:38AM

Monday, June 03, 2024

After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies
Vandana Singh - Jun 3, 2024, 12:35PM
Citigroup Maintains Buy on Arcus Biosciences,...
Benzinga Newsdesk - Jun 3, 2024, 11:13AM

Sunday, June 02, 2024

Gilead And Arcus Announced Etrumadenant Plus Zimberelimab, FOLFOX, And Bevacizumab Reduce Death Risk By 63% And Disease Progression by 73% vs Regorafenib In Phase 1b/2 Trial For Third-Line Metastatic Colorectal Cancer
Charles Gross - Jun 2, 2024, 10:36AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved